Resultados de la búsqueda 321-330 of 12618 for waardenburg syndrome
Patients with MIBG-avid, ALK wild type (or ALK unknown) disease will be randomized to one of three arms: A) current COG recommended high-risk therapy including ...
Most newly-diagnosed CLL patients have early-stage disease at the time of diagnosis and do not require treatment. Despite not needing therapy, these patients ...
... disease source, diagnosis, treatment, and prognosis. Clinical ... The purpose of this study is to determine adverse events and change in disease symptoms ...
ADPKD is a leading cause of end-stage renal disease. Recently, a new medication called Tolvaptan has been approved by the FDA to slow progression of ADPKD.
Accessed March 17, 2023. Bachem R, et al. Adjustment disorder: A diagnosis whose time has come. Journal of Affective Disorders. 2018; doi:10.1016/j.jad.2017.10.
Almost one-half million people suffer venous thromboembolism annually in the United States, and one-third die from this disease. Massive bleeding from ...
The natural course of autosomal dominant polycystic kidney disease (ADPKD) is highly variable and typically characterized by progressive enlargement of ...
Patients will receive treatment until disease progression, unacceptable toxicity, consent withdrawal or death occurs. ... Patients in the GDC-0199+R arm will ...
The goal of this research is to investigate the hypothesis that this presentation represents a spatially limited form of CNS inflammatory demyelinating disease.
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?